Pharmaceutical formulation
AssigneeSmithKline Beecham Corporation
InventorDaniel Joseph Burch
Life of this patent
Estimating the term…
Abstract
This invention relates to pharmaceutical formulations comprising amoxycillin and a salt clavulanic acid in a ratio of 14:1.
Claims56
A method for the empiric treatment of infections potentially caused by DRSP in a human patient in need thereof, comprising the oral administration to said patient of a pharmaceutical formulation comprising amoxycillin and clavulanate in which the dosage amount is from 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method of treating otitis media in a patient in need thereof which comprises administering to said patient a pharmaceutical formulation comprising a dosage amount of 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method of treating sinusitis in a patient in need thereof which comprises administering to said patient a pharmaceutical formulation comprising a dosage amount of 90±10% mg/kg of amoxycillin per day and from 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method of treating a respiratory infection in a patient in need thereof, which comprises administering to said patient a pharmaceutical formulation comprising a dosage amount of 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method of treating infections caused by DRSP in a patient in need thereof, which comprises administering to said patient a pharmaceutical formulation comprising a dosage amount of 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method of treating a Streptococcus pneumoniae infection in a patient in need thereof wherein the Streptococcus pneumoniae have a minimum inhibitory concentration value of 2 μg/ml, which comprises administering to said patient a pharmaceutical formulation comprising a dosage amount of 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method of treating a Streptococcus pneumoniae infection in a patient in need thereof wherein the Streptococcus pneumoniae have a minimum inhibitory concentration value of 4 μg/ml, which comprises administering to said patient a pharmaceutical formulation comprising a dosage amount of 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
A method for the empiric treatment of infections caused by bacterial infections in a human patient in need thereof, comprising the oral administration to said patient of a pharmaceutical formulation comprising amoxycillin and clavulanate in which the dosage amount is 90±10% mg/kg of amoxycillin per day and 6.4±10% mg/kg of clavulanate per day, said dosage amount being administered in divided doses twice daily.
Dependencies are inferred from the claim text.